Genpact (NYSE:G) had its price objective lowered by analysts at Citigroup from $39.00 to $37.50 in a research note issued on Tuesday, February 13th. The brokerage currently has a “buy” rating on the business services provider’s stock. Citigroup’s price target indicates a potential upside of 18.15% from the stock’s current price.
Other analysts also recently issued reports about the company. Cantor Fitzgerald restated a “buy” rating and issued a $36.00 price target on shares of Genpact in a research report on Wednesday, November 8th. Zacks Investment Research upgraded Genpact from a “sell” rating to a “hold” rating and set a $35.00 target price for the company in a research report on Friday, November 10th. Robert W. Baird reiterated a “buy” rating and set a $38.00 target price on shares of Genpact in a research report on Friday, November 10th. Finally, BMO Capital Markets raised their price target on Genpact to $35.00 and gave the company a “market perform” rating in a research note on Tuesday, February 13th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $34.65.
Genpact (NYSE G) traded up $0.35 on Tuesday, reaching $31.74. 830,715 shares of the company’s stock traded hands, compared to its average volume of 842,068. Genpact has a 1-year low of $23.34 and a 1-year high of $34.79. The company has a market cap of $6,123.62, a PE ratio of 23.54, a P/E/G ratio of 2.04 and a beta of 0.63. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.71.
Genpact (NYSE:G) last released its earnings results on Monday, February 12th. The business services provider reported $0.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.02. Genpact had a net margin of 9.61% and a return on equity of 22.75%. The company had revenue of $734.41 million during the quarter, compared to analyst estimates of $723.55 million. During the same period in the prior year, the firm posted $0.43 EPS. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. research analysts forecast that Genpact will post 1.55 earnings per share for the current fiscal year.
In other Genpact news, Director James C. Madden sold 4,270 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $30.92, for a total value of $132,028.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Arvinder Singh sold 22,690 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $33.95, for a total value of $770,325.50. The disclosure for this sale can be found here. Insiders have sold 49,815 shares of company stock valued at $1,638,971 in the last ninety days. Corporate insiders own 1.41% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. American International Group Inc. purchased a new stake in shares of Genpact during the fourth quarter worth approximately $114,000. Meeder Asset Management Inc. purchased a new stake in Genpact in the 3rd quarter valued at $128,000. Advisor Group Inc. grew its holdings in Genpact by 59.8% in the 3rd quarter. Advisor Group Inc. now owns 5,017 shares of the business services provider’s stock valued at $145,000 after buying an additional 1,878 shares in the last quarter. The Manufacturers Life Insurance Company grew its holdings in Genpact by 7.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock valued at $181,000 after buying an additional 455 shares in the last quarter. Finally, Verition Fund Management LLC purchased a new stake in Genpact in the 2nd quarter valued at $210,000. Institutional investors and hedge funds own 89.97% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://ledgergazette.com/2018/03/09/genpact-g-given-new-37-50-price-target-at-citigroup.html.
Genpact Company Profile
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.